Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,883,201
-$883,379 QoQ
Shares Held
15,290
-21.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,791
of 4,664 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOCHK Asset Management Ltd holds $32,542,832 across 7 Drug Manufacturers - General names. JNJ ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,590 | $10,465,707 | |
| 2 | LLY |
ELI LILLY & Co
|
6,610 | $7,928,232 | |
| 3 | MRK |
Merck & Co., Inc.
|
44,360 | $5,700,260 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
15,290 | $3,883,201 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
19,800 | $2,501,532 | |
| 6 | AMGN |
Amgen Inc
|
5,500 | $1,991,660 | |
| 7 | PFE |
Pfizer Inc
|
3,000 | $72,240 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,883,201 | 15,290 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,766,580 | 19,500 | Shares | Sole | 2026-05-06 | |
| 2025-06-30 | $152,750 | 1,000 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $120,179 | 831 | Shares | Sole | 2025-01-23 | |
| 2024-03-31 | $316,380 | 2,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $313,480 | 2,000 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||